Used in pharmaceutical research as a potent and selective inhibitor of tyrosine kinases, particularly targeting pathways involved in cancer cell proliferation and survival. Shows promise in the development of targeted therapies for solid tumors and hematologic malignancies. Its structure enables high binding affinity to specific kinase domains, improving efficacy and reducing off-target effects. Also employed in medicinal chemistry studies to optimize drug candidates with improved pharmacokinetic profiles.